BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3871666)

  • 1. Augmentation of cytotoxic responses by prostaglandin E2.
    Häcker-Shahin B; Dröge W
    Cell Immunol; 1985 Mar; 91(1):43-51. PubMed ID: 3871666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of cytotoxic responses by prostaglandin E2 in the presence of interleukin 2.
    Wolf M; Droege W
    Cell Immunol; 1982 Sep; 72(2):286-93. PubMed ID: 6983912
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of prostaglandins on the development of cell-mediated immunity in culture and on the cytolytic activity of in vivo-generated effector cells.
    Leung KH; Mihich E
    Int J Immunopharmacol; 1982; 4(3):205-17. PubMed ID: 6809648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenically activated helper T cells are required as stimulator cells for optimal activation of cytotoxic T lymphocytes under conditions of limiting helper factors.
    Moyers C; Droege W
    Cell Immunol; 1983 Jan; 75(1):1-12. PubMed ID: 6218891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Capacity of different cell types to stimulate cytotoxic T lymphocyte precursor cells in the presence of interleukin 2.
    Dröge W; Moyers C; Wehrmaker A; Schmidt H; Panknin S; Männel D; Falk W
    J Immunol; 1984 Jun; 132(6):2749-59. PubMed ID: 6233360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of alloimmune cytotoxic T lymphocyte (CTL) generation by depletion of NK cells and restoration by interferon and/or interleukin 2.
    Suzuki R; Suzuki S; Ebina N; Kumagai K
    J Immunol; 1985 Apr; 134(4):2139-48. PubMed ID: 2579129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cytotoxic T lymphocytes requires at least two spleen cell-derived helper factors besides interleukin 2.
    Falk W; Männel DN; Dröge W
    J Immunol; 1983 May; 130(5):2214-8. PubMed ID: 6220085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneal adherent cell inhibit the generation of cytotoxic T lymphocytes with prostaglandin-mediated system.
    Koga Y; Taniguchi K; Kubo C; Nomoto K
    Cell Immunol; 1982 Jan; 66(1):195-201. PubMed ID: 6211243
    [No Abstract]   [Full Text] [Related]  

  • 9. The combined effect of prostaglandin E2 and interleukin 1 on interleukin 2 production and lymphocyte proliferation.
    Maca RD
    Int J Immunopharmacol; 1987; 9(5):611-8. PubMed ID: 3497889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandin E2 mediates subset-specific effects on the functional responses of allosensitized T lymphocyte clones.
    Jordan ML; Hoffman RA; Debe EF; West MA; Simmons RL
    Transplantation; 1987 Jan; 43(1):117-23. PubMed ID: 2948306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in proliferation and cytotoxic cell development in human mixed lymphocyte cultures in the presence of very low concentrations of LPS: role of IL-1 and prostaglandin E2.
    Spear GT; Marshall P; Teodorescu M
    Clin Immunol Immunopathol; 1986 Jan; 38(1):32-46. PubMed ID: 3000663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prostaglandins on elicitation of anti-viral-cytolytic activity.
    Hale AH; Evans DL; Daniel LW
    Immunol Lett; 1982 Mar; 4(3):171-4. PubMed ID: 6281179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of mixed leukocyte reaction and cytotoxic antitumor responses by heparin.
    Dziarski R
    J Immunol; 1989 Jul; 143(1):356-65. PubMed ID: 2471741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of natural killer-derived cytotoxic T lymphocytes. I. Regulation by macrophage and prostaglandins.
    Ting CC; Hargrove ME
    J Immunol; 1983 Oct; 131(4):1734-41. PubMed ID: 6604751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of antitumor immunity by indomethacin.
    Morecki S; Yacovlev E; Gelfand Y; Trembovler V; Shohami E; Slavin S
    Cancer Immunol Immunother; 2000 Feb; 48(11):613-20. PubMed ID: 10663608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of experimental conditions on the assessment of T cell immunomodulation by biological response modifiers (thymosin fraction five).
    Talmadge JE; Benedict KL; Uithoven KA; Lenz BF
    Immunopharmacology; 1984 Feb; 7(1):17-26. PubMed ID: 6232241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro locomotion of allosensitized T lymphocyte clones in response to metabolites of arachidonic acid is subset specific.
    Jordan ML; Hoffman RA; Debe EF; Simmons RL
    J Immunol; 1986 Jul; 137(2):661-8. PubMed ID: 3013998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of spleen cell cytotoxic capacity toward tumor by elevated prostaglandin E2 levels in mice bearing Lewis lung carcinoma.
    Young MR; Hoover CS
    J Natl Cancer Inst; 1986 Aug; 77(2):425-9. PubMed ID: 2942724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T-cell cytotoxicity and aging: differing causes of reduced response in individual mice.
    Zharhary D; Segev Y; Gershon HE
    Mech Ageing Dev; 1984; 25(1-2):129-40. PubMed ID: 6233460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.